Bortezomib Related Products
Bortezomib is a medication used to treat multiple myeloma, a type of blood cancer.It is available as a generic medication.
Vsquare is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Bortezomib, pharmacopeial and non-pharmacopeial Bortezomib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Bortezomib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Bortezomib-related products are thoroughly characterized. Bortezomib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.
Pharmaceutical Reference Standards
(S,R)-Bortezomib Hydroxyisopentyl Amide Analog
| VS CAT No | : VS-B004005 |
| CAS No | : 289472-78-2 |
| Mol.F. | : C19H24N4O3 |
| Mol.Wt. | : 356.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib
| VS CAT No | : VS-B004001 |
| CAS No | : 179324-69-7 |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
| Inv. Status | : In Stock |
Bortezomib
| VS CAT No | : VS-B004001 |
| CAS No | : 179324-69-7 |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
| Inv. Status | : In Stock |
Bortezomib Amino R Isomer (TFA salt)
| VS CAT No | : VS-B004056 |
| CAS No | : 179324-87-9 |
| Mol.F. | : C15H28BNO2 : C2HF3O2 |
| Mol.Wt. | : 265.2 : 114.0 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 179324-86-8 (Free base) |
Bortezomib D-Mannitol Ester
| VS CAT No | : VS-B004126 |
| CAS No | : 444576-08-3 |
| Mol.F. | : C25H35BN4O8 |
| Mol.Wt. | : 530.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Ester Impurity
| VS CAT No | : VS-B004106 |
| CAS No | : NA |
| Mol.F. | : C29H39BN4O4 |
| Mol.Wt. | : 518.5 |
| Inv. Status | : Custom Synthesis |
Bortezomib Hydroxy Ketone Analog
| VS CAT No | : VS-B004010 |
| CAS No | : 2379402-85-2 |
| Mol.F. | : C19H22N4O4 |
| Mol.Wt. | : 370.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity (R,R-Isomer)
| VS CAT No | : VS-B004002 |
| CAS No | : 1132709-15-9 |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity (R,S-Isomer)
| VS CAT No | : VS-B004003 |
| CAS No | : 1132709-16-0 |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity (S,S-Isomer)
| VS CAT No | : VS-B004004 |
| CAS No | : 1132709-14-8 |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 11
| VS CAT No | : VS-B004016 |
| CAS No | : 862895-00-9 |
| Mol.F. | : C19H22N4O2 |
| Mol.Wt. | : 338.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 14
| VS CAT No | : VS-B004019 |
| CAS No | : 205393-22-2 |
| Mol.F. | : C29H39BN4O4 |
| Mol.Wt. | : 518.5 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 1187479-73-7 (HCl salt) |
Bortezomib Impurity 15
| VS CAT No | : VS-B004096 |
| CAS No | : 1259365-04-2 |
| Mol.F. | : C11H24BNO2 |
| Mol.Wt. | : 213.1 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 1259300-03-2 (HCl salt) |
Bortezomib Impurity 16
| VS CAT No | : VS-B004021 |
| CAS No | : NA |
| Mol.F. | : C19H24N4O3 |
| Mol.Wt. | : 356.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 17
| VS CAT No | : VS-B004022 |
| CAS No | : NA |
| Mol.F. | : C19H25BN4O5 |
| Mol.Wt. | : 400.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 18
| VS CAT No | : VS-B004023 |
| CAS No | : NA |
| Mol.F. | : C38H46N8O6 |
| Mol.Wt. | : 710.8 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 2 (Mixture of (1S,2R)-Isomer and (1R,2R)-Isomer)
| VS CAT No | : VS-B004007 |
| CAS No | : 2747958-64-9 |
| Mol.F. | : C19H24N4O3 |
| Mol.Wt. | : 356.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 2 (RR-Isomer)
| VS CAT No | : VS-B004006 |
| CAS No | : NA |
| Mol.F. | : C19H24N4O3 |
| Mol.Wt. | : 356.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 20
| VS CAT No | : VS-B004025 |
| CAS No | : 89618-77-9 |
| Mol.F. | : C14H24BClO2 |
| Mol.Wt. | : 270.6 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 21
| VS CAT No | : VS-B004026 |
| CAS No | : 94242-79-2 |
| Mol.F. | : C20H42BNO2Si2 |
| Mol.Wt. | : 395.6 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 23
| VS CAT No | : VS-B004028 |
| CAS No | : NA |
| Mol.F. | : C14H24BClO2 |
| Mol.Wt. | : 270.6 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 25
| VS CAT No | : VS-B004097 |
| CAS No | : 94242-80-5 |
| Mol.F. | : C14H26BNO2 |
| Mol.Wt. | : 251.2 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 26
| VS CAT No | : VS-B004031 |
| CAS No | : 78-77-3 |
| Mol.F. | : C4H9Br |
| Mol.Wt. | : 137.0 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 27
| VS CAT No | : VS-B004032 |
| CAS No | : 63-91-2 |
| Mol.F. | : C9H11NO2 |
| Mol.Wt. | : 165.2 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 28
| VS CAT No | : VS-B004033 |
| CAS No | : 18942-49-9 |
| Mol.F. | : C14H19NO4 |
| Mol.Wt. | : 265.3 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 169131-65-1 (HCl salt) ; 1013327-78-0 (Na salt) |
Bortezomib Impurity 29
| VS CAT No | : VS-B004034 |
| CAS No | : 89-01-0 |
| Mol.F. | : C6H4N2O4 |
| Mol.Wt. | : 168.1 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 93778-20-2 (Na salt) ; 859063-48-2 (K salt) |
Bortezomib Impurity 3
| VS CAT No | : VS-B004008 |
| CAS No | : NA |
| Mol.F. | : C14H14N4O2 : HCl |
| Mol.Wt. | : 270.3 : 36.5 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 2748159-75-1 (free base) |
Bortezomib Impurity 30
| VS CAT No | : VS-B004035 |
| CAS No | : 513-36-0 |
| Mol.F. | : C4H9Cl |
| Mol.Wt. | : 92.6 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 31
| VS CAT No | : VS-B004036 |
| CAS No | : 84110-40-7 |
| Mol.F. | : C4H11BO2 |
| Mol.Wt. | : 101.9 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 32
| VS CAT No | : VS-B004037 |
| CAS No | : 2363753-29-9 |
| Mol.F. | : C15H28BNO2 : C2HF3O2 |
| Mol.Wt. | : 265.2 : 114.0 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 1173239-14-9 (Free base) |
Bortezomib Impurity 33
| VS CAT No | : VS-B004038 |
| CAS No | : 948294-96-0 |
| Mol.F. | : C14H23BN2O3 |
| Mol.Wt. | : 278.2 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 2413962-44-2 (HCl salt) |
Bortezomib Impurity 35
| VS CAT No | : VS-B004040 |
| CAS No | : NA |
| Mol.F. | : C28H34BN5O5 |
| Mol.Wt. | : 531.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 36
| VS CAT No | : VS-B004041 |
| CAS No | : 114457-94-2 |
| Mol.F. | : C14H13N3O3 |
| Mol.Wt. | : 271.3 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 1093959-75-1 (Na salt) ; 1093959-76-2 (K salt) |
Bortezomib Impurity 37
| VS CAT No | : VS-B004058 |
| CAS No | : 1798895-16-5 |
| Mol.F. | : C15H15N3O3 |
| Mol.Wt. | : 285.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 38
| VS CAT No | : VS-B004059 |
| CAS No | : 18680-27-8 |
| Mol.F. | : C10H18O2 |
| Mol.Wt. | : 170.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 4
| VS CAT No | : VS-B004009 |
| CAS No | : 862894-96-0 |
| Mol.F. | : C19H22N4O3 |
| Mol.Wt. | : 354.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 40
| VS CAT No | : VS-B004061 |
| CAS No | : 85167-14-2 |
| Mol.F. | : C15H26BClO2 |
| Mol.Wt. | : 284.6 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 41
| VS CAT No | : VS-B004064 |
| CAS No | : 514820-48-5 |
| Mol.F. | : C21H44BNO2Si2 |
| Mol.Wt. | : 409.6 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 42
| VS CAT No | : VS-B004070 |
| CAS No | : 477254-69-6 |
| Mol.F. | : C15H28BNO2 : C2HF3O2 |
| Mol.Wt. | : 265.2 : 114.0 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 477254-68-5 (Free base) |
Bortezomib Impurity 43
| VS CAT No | : VS-B004078 |
| CAS No | : NA |
| Mol.F. | : C28H37BN4O4 |
| Mol.Wt. | : 504.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 44
| VS CAT No | : VS-B004080 |
| CAS No | : 2308-61-4 |
| Mol.F. | : C18H18N2O2 |
| Mol.Wt. | : 294.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 45
| VS CAT No | : VS-B004082 |
| CAS No | : 1255646-95-7 |
| Mol.F. | : C17H18N2O3 |
| Mol.Wt. | : 298.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 46
| VS CAT No | : VS-B004083 |
| CAS No | : 2577-40-4 |
| Mol.F. | : C18H20N2O3 |
| Mol.Wt. | : 312.4 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 68800-30-6 (HCl salt) ; 1087344-12-4 (HBr salt) ; 1841445-65-5 (Na salt) ; 1307315-69-0 (TFA salt) |
Bortezomib Impurity 47
| VS CAT No | : VS-B004084 |
| CAS No | : 1194235-14-7 |
| Mol.F. | : C23H22N4O4 |
| Mol.Wt. | : 418.5 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 48
| VS CAT No | : VS-B004085 |
| CAS No | : NA |
| Mol.F. | : C57H69B3N12O9 |
| Mol.Wt. | : 1098.7 |
| Inv. Status | : In Stock |
Bortezomib Impurity 50
| VS CAT No | : VS-B004087 |
| CAS No | : NA |
| Mol.F. | : C57H69B3N12O9 |
| Mol.Wt. | : 1098.7 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 51
| VS CAT No | : VS-B004088 |
| CAS No | : NA |
| Mol.F. | : C27H35BN4O4 |
| Mol.Wt. | : 490.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 53
| VS CAT No | : VS-B004090 |
| CAS No | : 2364553-64-8 |
| Mol.F. | : C14H13N3O3 |
| Mol.Wt. | : 271.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 54
| VS CAT No | : VS-B004091 |
| CAS No | : 110755-29-8 |
| Mol.F. | : C14H22N2O |
| Mol.Wt. | : 234.3 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 292061-26-8 (HCl salt) |
Bortezomib Impurity 56
| VS CAT No | : VS-B004093 |
| CAS No | : 4664-57-7 |
| Mol.F. | : C11H16O3S |
| Mol.Wt. | : 228.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 6
| VS CAT No | : VS-B004011 |
| CAS No | : NA |
| Mol.F. | : C19H25BN4O5 |
| Mol.Wt. | : 400.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 7
| VS CAT No | : VS-B004012 |
| CAS No | : NA |
| Mol.F. | : C10H16BN3O3 |
| Mol.Wt. | : 237.1 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 7
| VS CAT No | : VS-B004012 |
| CAS No | : NA |
| Mol.F. | : C10H16BN3O3 |
| Mol.Wt. | : 237.1 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 70
| VS CAT No | : VS-B004107 |
| CAS No | : NA |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 71
| VS CAT No | : VS-B004108 |
| CAS No | : 1579304-37-2 |
| Mol.F. | : C29H39BN4O4 |
| Mol.Wt. | : 518.5 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 72
| VS CAT No | : VS-B004109 |
| CAS No | : NA |
| Mol.F. | : C22H30N4O4 |
| Mol.Wt. | : 414.5 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 73
| VS CAT No | : VS-B004110 |
| CAS No | : NA |
| Mol.F. | : C22H30N4O4 |
| Mol.Wt. | : 414.5 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 74
| VS CAT No | : VS-B004111 |
| CAS No | : NA |
| Mol.F. | : C22H30N4O4 |
| Mol.Wt. | : 414.5 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 76
| VS CAT No | : VS-B004123 |
| CAS No | : NA |
| Mol.F. | : C19H24N4O2 |
| Mol.Wt. | : 340.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 77
| VS CAT No | : VS-B004124 |
| CAS No | : NA |
| Mol.F. | : C19H24N4O3 |
| Mol.Wt. | : 356.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 78
| VS CAT No | : VS-B004125 |
| CAS No | : 1135491-84-7 |
| Mol.F. | : C21H44BNO2Si2 |
| Mol.Wt. | : 409.6 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 79
| VS CAT No | : VS-B004127 |
| CAS No | : NA |
| Mol.F. | : C29H39BN4O4 |
| Mol.Wt. | : 518.5 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 8
| VS CAT No | : VS-B004013 |
| CAS No | : NA |
| Mol.F. | : C24H27BN6O5 |
| Mol.Wt. | : 490.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 80
| VS CAT No | : VS-B004128 |
| CAS No | : 2748159-75-1 |
| Mol.F. | : C14H14N4O2 |
| Mol.Wt. | : 270.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 81
| VS CAT No | : VS-B004129 |
| CAS No | : NA |
| Mol.F. | : C25H36BN5O4 |
| Mol.Wt. | : 481.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity 9
| VS CAT No | : VS-B004014 |
| CAS No | : 1194235-41-0 |
| Mol.F. | : C28H34BN5O5 |
| Mol.Wt. | : 531.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity A
| VS CAT No | : VS-B004044 |
| CAS No | : 289472-80-6 |
| Mol.F. | : C14H14N4O2 |
| Mol.Wt. | : 270.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity B
| VS CAT No | : VS-B004018 |
| CAS No | : NA |
| Mol.F. | : C28H37BN4O5 |
| Mol.Wt. | : 520.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity C (Mixture of Isomers)
| VS CAT No | : VS-B004045 |
| CAS No | : NA |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity F
| VS CAT No | : VS-B004046 |
| CAS No | : 73058-37-4 |
| Mol.F. | : C15H15N3O3 |
| Mol.Wt. | : 285.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity G
| VS CAT No | : VS-B004047 |
| CAS No | : 289472-81-7 |
| Mol.F. | : C19H24N4O3 |
| Mol.Wt. | : 356.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity H
| VS CAT No | : VS-B004048 |
| CAS No | : 1446194-56-4 |
| Mol.F. | : C19H24N4O2 |
| Mol.Wt. | : 340.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity M
| VS CAT No | : VS-B004049 |
| CAS No | : NA |
| Mol.F. | : C19H24N4O4 |
| Mol.Wt. | : 372.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Impurity N
| VS CAT No | : VS-B004050 |
| CAS No | : NA |
| Mol.F. | : C19H24N4O4 |
| Mol.Wt. | : 372.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Intermediate(R,S)
| VS CAT No | : VS-B004051 |
| CAS No | : 2363753-37-9 |
| Mol.F. | : C14H25BO2 |
| Mol.Wt. | : 236.2 |
| Inv. Status | : Custom Synthesis |
Bortezomib Intermediate(S,R)
| VS CAT No | : VS-B004052 |
| CAS No | : 84110-34-9 |
| Mol.F. | : C14H25BO2 |
| Mol.Wt. | : 236.2 |
| Inv. Status | : Custom Synthesis |
Bortezomib Isoamyl Impurity
| VS CAT No | : VS-B004057 |
| CAS No | : 1375004-39-9 |
| Mol.F. | : C29H39BN4O4 |
| Mol.Wt. | : 518.5 |
| Inv. Status | : Custom Synthesis |
Bortezomib R and S Hydroperoxide
| VS CAT No | : VS-B004079 |
| CAS No | : NA |
| Mol.F. | : 2(C19H24N4O4) |
| Mol.Wt. | : 2(372.4) |
| Inv. Status | : Custom Synthesis |
Bortezomib R-Hydroperoxide
| VS CAT No | : VS-B004054 |
| CAS No | : 886979-78-8 |
| Mol.F. | : C19H24N4O4 |
| Mol.Wt. | : 372.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Related Compaund K
| VS CAT No | : VS-B004069 |
| CAS No | : NA |
| Mol.F. | : C38H47N8O6 |
| Mol.Wt. | : 711.8 |
| Inv. Status | : Custom Synthesis |
Bortezomib Related Compound E
| VS CAT No | : VS-B004063 |
| CAS No | : NA |
| Mol.F. | : C15H14N4O3 |
| Mol.Wt. | : 298.3 |
| Inv. Status | : Custom Synthesis |
Bortezomib Related Compound P
| VS CAT No | : VS-B004074 |
| CAS No | : NA |
| Mol.F. | : C28H34BN5O5 |
| Mol.Wt. | : 531.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Related Impurity E
| VS CAT No | : VS-B004042 |
| CAS No | : NA |
| Mol.F. | : C20H26N4O3 |
| Mol.Wt. | : 370.5 |
| Inv. Status | : Custom Synthesis |
Bortezomib Related Impurity F
| VS CAT No | : VS-B004043 |
| CAS No | : NA |
| Mol.F. | : C20H26N4O3 |
| Mol.Wt. | : 370.5 |
| Inv. Status | : Custom Synthesis |
Bortezomib S-Hydroperoxide
| VS CAT No | : VS-B004055 |
| CAS No | : 886979-81-3 |
| Mol.F. | : C19H24N4O4 |
| Mol.Wt. | : 372.4 |
| Inv. Status | : Custom Synthesis |
Bortezomib Stereo Isomers Mixture
| VS CAT No | : VS-B004094 |
| CAS No | : NA |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
| Inv. Status | : Custom Synthesis |
Bortezomib Trimer
| VS CAT No | : VS-B004015 |
| CAS No | : 390800-88-1 |
| Mol.F. | : C57H69B3N12O9 |
| Mol.Wt. | : 1098.7 |
| Inv. Status | : Custom Synthesis |
Desisobutyl-n-butyl Bortezomib
| VS CAT No | : VS-B004122 |
| CAS No | : 1104011-35-9 |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
| Inv. Status | : Custom Synthesis |
N-(2-pyraziny| carbony|)-D-Phenylalanine
| VS CAT No | : VS-B004053 |
| CAS No | : 1608986-16-8 |
| Mol.F. | : C14H13N3O3 |
| Mol.Wt. | : 271.3 |
| Inv. Status | : Custom Synthesis |
Phenylalanine Dimer Impurity
| VS CAT No | : VS-B004081 |
| CAS No | : NA |
| Mol.F. | : C22H20N4O4 |
| Mol.Wt. | : 404.4 |
| Inv. Status | : Custom Synthesis |
Stable Isotopes And Metabolites
Bortezomib d5
| VS CAT No | : VS-B004D01 |
| CAS No | : 1133706-15-6 |
| Mol.F. | : C19H20D5BN4O4 |
| Mol.Wt. | : 389.3 |
| Inv. Status | : Custom Synthesis |